PDLIM2 and lung carcinoma: In line with its role in promoting ubiquitination and proteasomal degradation of nuclear RelA and STAT321–23, PDLIM2 deletion increased while its expression decreased nuclear RelA and STAT3, a hallmark of NF-κB and STAT3 activation, in lung cancer cells (Fig. 6a, b).